GlassScriptPhysician profile
Mindi A Lemonds
NPI 1306560818
$6,345.52
in general payments reported to CMS, 2019-2025
40 companies · $2,630 in 2025
The $2,630 reported for 2025 was more than what 96% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,110 · 2024: $2,605 · 2025: $2,630.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,423 · Travel and Lodging: $820 · Education: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,423.14 |
| Travel and Lodging | $819.88 |
| Education | $102.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,561.70 | 2023-2025 | General - Pain Management, Wavewriter Alpha Prime 16, Watchman Flx |
| Abbvie INC. | $936.94 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $537.34 | 2023-2025 | |
| Biogen, INC. | $427.18 | 2023-2025 | Vumerity, Tysabri, Skyclarys |
| Pfizer INC. | $299.06 | 2023-2025 | |
| Argenx US, INC. | $251.17 | 2024-2025 | Vyvgart Hytrulo, Vyvgart |
| Janssen Biotech, INC. | $225.38 | 2025 | |
| Lundbeck LLC | $213.24 | 2023-2025 | Vyepti |
| Emd Serono, INC. | $199.78 | 2023-2024 | Mavenclad |
| Ani Pharmaceuticals, INC. | $193.47 | 2023-2025 | Purified Cortrophin Gel |
| Alexion Pharmaceuticals, INC. | $149.71 | 2024-2025 | Ultomiris |
| Merz Pharmaceuticals, LLC | $127.97 | 2024-2025 | Xeomin, Inbrija |
| Ucb, INC. | $125.25 | 2024-2025 | Rystiggo, Zilbrysq |
| E.R. Squibb & Sons, L.L.C. | $114.92 | 2023 | Zeposia |
| Genentech USA, INC. | $104.29 | 2023-2025 | Ocrevus Zunovo, Ocrevus, Enspryng |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $94.03 | 2023-2025 | Nuplazid |
| Neurocrine Biosciences, INC. | $77.77 | 2023-2025 | Ingrezza, Ongentys |
| Amgen INC. | $75.18 | 2025 | Evenity |
| Lilly USA, LLC | $68.22 | 2024-2025 | Kisunla, Amyvid |
| Tanabe Pharma America, INC. | $58.50 | 2023-2025 | Radicava |
| Celgene Corporation | $51.71 | 2023-2025 | Zeposia |
| Amneal Pharmaceuticals LLC | $48.75 | 2024 | Rytary, Ongentys |
| Csl Behring | $46.69 | 2025 | Hizentra |
| Collegium Pharmaceutical, INC. | $38.34 | 2023-2024 | Xtampza, Belbuca |
| Otsuka America Pharmaceutical, INC. | $36.57 | 2025 | Rexulti |
| Mallinckrodt Hospital Products INC. | $29.50 | 2025 | Acthar |
| Astrazeneca Pharmaceuticals LP | $24.48 | 2025 | |
| Jazz Pharmaceuticals INC. | $24.32 | 2024 | |
| Grifols USA, LLC | $23.96 | 2025 | Gamunex-C |
| Eisai INC. | $20.61 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.82 | 2024 | Hyqvia |
| Radius Health, INC. | $19.34 | 2025 | Tymlos |
| Spr Therapeutics, INC | $17.68 | 2024 | Sprint Pns System |
| Cycle Pharmaceuticals INC | $16.53 | 2025 | Bafiertam |
| Averitas Pharma INC. | $16.05 | 2023 | Qutenza |
| Actelion Pharmaceuticals US, INC. | $15.57 | 2025 | Opsumit, Uptravi |
| Banner Life Sciences, LLC | $15.35 | 2024 | |
| Medtronic, INC. | $14.22 | 2024 | Percept PC Brainsense |
| Sobi, INC | $14.16 | 2025 | |
| Insightec,INC | $10.77 | 2024 | Exablate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mindi Lemonds listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.